Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 10 de 10
Filter
1.
Transplant Proc ; 50(5): 1332-1335, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29880354

ABSTRACT

BACKGROUND: Modifications of erythrocyte membrane fatty acid (FA) contents may affect cellular function or transmembrane receptors. One cross-sectional study has shown that kidney transplant (KTP) recipients have lower erythrocyte membrane oleic acid content than dialysis patients do. Therefore, we prospectively tested whether erythrocyte membrane contents of FA including oleic acid change after KTP. METHODS: We recruited 23 KTP recipients (September 2011 through May 2014). Blood samples were obtained immediately before KTP and 6 months after. Erythrocyte membrane FA contents were measured by gas chromatography. RESULTS: Mean age of the enrolled KTP recipients was 45.3 ± 10.9 years, and men represented 66.7% of the cases. ABO-incompatible KTPs constituted 14.3% and cadaver donors 42.9% of the cases. Steroids, mycophenolate mofetil, and tacrolimus were used as immunosuppressive treatment. There was no significant difference in dietary consumption between time points before and 6 months after KTP. Total cholesterol and low-density lipoprotein cholesterol levels were significantly higher at 6 months after KTP as compared with baseline. Erythrocyte membrane contents of polyunsaturated FA, ω-3 FA, ω-6 FA, and the ω-3 index were significantly higher, but erythrocyte membrane contents of total saturated FAs, total monounsaturated FAs, including oleic acid, total trans-FA, palmitoleic acid, and the ω-6-to-ω-3 ratio were significantly lower at 6 months after KTP. CONCLUSIONS: Erythrocyte membrane FA contents significantly changed toward a more favorable cardiovascular profile after KTP. These changes in erythrocyte membrane FA contents may be related to improved renal function because of the absence of significant dietary changes.


Subject(s)
Erythrocyte Membrane/metabolism , Fatty Acids/blood , Kidney Transplantation , Adult , Chromatography, Gas , Cross-Sectional Studies , Erythrocyte Membrane/chemistry , Female , Humans , Male , Middle Aged , Prospective Studies
2.
Transplant Proc ; 45(2): 756-62, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23498817

ABSTRACT

OBJECTIVES: Protein kinase casein kinase II (PKCK2) has multiple, overlapping roles in induction of apoptosis. Apoptosis can be a common pathway of renal injury caused by a nephrotoxic drug or an injury. We evaluated the role of PKCK2 in cyclosporine (CsA)-induced nephropathy in rats by inhibiting PKCK2 with emodin. METHODS: Male Sprague-Dawley rats fed a low-sodium diet were divided into four treatment groups: control (0.9% saline injection), CsA (15 mg/kg/d subcutaneously), CsA + emodin (CsA plus emodin 20 mg/kg/d subcutaneously), and emodin only. The expression levels of apoptosis-associated factors and of PKCK2 were examined by Western blot analysis. RESULTS: Overexpression of PKCK2 noted with CsA treatment was prevented by emodin, a low-molecular-weight PKCK2 inhibitor, which dampend drug-induced up-regulation phosphorylated p53 and activation of caspases 3, 7, and 8. In addition, emodin prevented increased Bax/Bcl-2 ratio induced by CsA. Emodin prevented up-regulation of PKCK2 by CsA treatment, suggesting that its apoptotic-preventing activity was mediated via PKCK2. CONCLUSIONS: Our findings indicated that PKCK2 may play a role in apoptotic injury associated with CsA-induced nephropathy in rats.


Subject(s)
Casein Kinase II/metabolism , Cyclosporine , Kidney Diseases/enzymology , Kidney/enzymology , Animals , Apoptosis , Blotting, Western , Casein Kinase II/antagonists & inhibitors , Caspase 3/metabolism , Caspase 7/metabolism , Caspase 8/metabolism , Diet, Sodium-Restricted , Disease Models, Animal , Emodin/pharmacology , Immunohistochemistry , Kidney/drug effects , Kidney/pathology , Kidney Diseases/chemically induced , Kidney Diseases/pathology , Kidney Diseases/prevention & control , Male , Phosphorylation , Protein Kinase Inhibitors/pharmacology , Proto-Oncogene Proteins c-bcl-2/metabolism , Rats , Rats, Sprague-Dawley , Tumor Suppressor Protein p53/metabolism , bcl-2-Associated X Protein/metabolism
3.
Int J Cardiovasc Imaging ; 29(2): 295-9, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22772474

ABSTRACT

Femoral veins are commonly used as a relatively safe alternative route for central venous cannulation. Several maneuvers are used to increase the cross-sectional area of the vein. In this study, we assessed the effect of positive end-expiratory pressure (PEEP) on the cross-sectional area (CSA) of femoral veins, using ultrasound in adult patients under positive pressure ventilation. All patients received a standardized induction of general anesthesia and intravenous fluid administration. Using ultrasound, the cross-sectional areas of both femoral veins were measured in 57 adult patients in the supine position without PEEP (control) and in the supine position with PEEP of 10 cm H(2)O. Mean arterial pressure and heart rate were recorded before and after the application of PEEP at 10 cm H(2)O. The application of 10 cm H(2)O PEEP significantly increased the CSA of the right femoral vein by 47.6 % and the left femoral vein by 48.4 % (each P < 0.001). Mean arterial pressure decreased by 2.6 mmHg (95 % CI 1.3-3.9; P < 0.001), whereas no significant change in heart rate was observed (P = 0.861). The CSA of the femoral vein is augmented with the application of 10 cm H(2)O PEEP in adult patients undergoing positive pressure ventilation.


Subject(s)
Catheterization, Central Venous/methods , Femoral Vein/diagnostic imaging , Positive-Pressure Respiration , Adult , Aged , Anesthesia, General , Arterial Pressure , Female , Femoral Vein/physiopathology , Heart Rate , Humans , Male , Middle Aged , Patient Positioning , Prospective Studies , Single-Blind Method , Supine Position , Ultrasonography
4.
Transplant Proc ; 44(10): 2932-5, 2012 Dec.
Article in English | MEDLINE | ID: mdl-23195000

ABSTRACT

BACKGROUND: Alterations of erythrocyte membrane fatty acid (FA) composition play important roles in cellular function because they change the membrane microenvironment, including transmembrane receptors. The erythrocyte membrane oleic acid content is higher among patients with acute coronary syndrome and also in dialysis patients. However, available data are limited concerning erythrocyte membrane FA content in kidney transplant recipients (KTP). We sought to test the hypothesis that erythrocyte membrane FA content among KTP were different from those in dialysis patients. METHODS: In this cross-sectional study, we recruited 35 hemodialysis, 33 peritoneal dialysis 49 KTP, and 33 normal control subjects (CTL). Their erythrocyte membrane FA content were measured by gas chromatography. RESULTS: The mean ages of the enrolled dialysis patients, KTP, and CTL were 56.4 ± 10.1, 48.9 ± 10.4, and 49.5 ± 8.3 years, respectively. Mean kidney transplant duration was 89.8 ± 64.8 months and mean dialysis duration, 49.0 ± 32.6 months. The intakes of vegetable lipid and vegetable protein including total calories were significantly increased among KTP versus dialysis patients. Total cholesterol (P < .001) and high density lipoprotein cholesterol (HDL; P < .001) levels were significantly higher and C-reactive protein was significantly lower among KTP compared with dialysis patients. The erythrocyte membrane content of palmitoleic acid (P < .001) was significantly higher but oleic acid (P < .001) significantly lower in KTP compared with dialysis patients. The erythrocyte membrane contents of arachidonic acid and docosahexaenoic acid were significantly higher, and linoleic acid and the omega-6 FA to omega-3 FA ratio (P < .001) significantly lower in KTP compared with dialysis patients. The erythrocyte membrane content of oleic acid was independently associated with monounsaturated fatty acid (beta = 0.771, P < .001), eicosapentaeonic acid (beta = -0.244, P = .010), and HDL (beta = -0.139, P = .049) in KTP. CONCLUSIONS: FA contents of erythrocyte membranes were significantly different in KTP compared with dialysis patients. These differences may have been associated with improved dietary intake and immunosuppression after kidney transplantation.


Subject(s)
Erythrocyte Membrane/metabolism , Fatty Acids/blood , Kidney Diseases/therapy , Kidney Transplantation , Peritoneal Dialysis , Renal Dialysis , Adult , Aged , Aged, 80 and over , Chi-Square Distribution , Chromatography, Gas , Cross-Sectional Studies , Erythrocyte Membrane/drug effects , Female , Humans , Immunosuppressive Agents/therapeutic use , Kidney Diseases/blood , Kidney Diseases/surgery , Linear Models , Logistic Models , Male , Middle Aged , Nutritional Status , Time Factors , Treatment Outcome , Young Adult
5.
Article in English | MEDLINE | ID: mdl-22071008

ABSTRACT

Erythrocyte membrane fatty acids (FA), such as oleic acid, are related to acute coronary syndrome. There is no report about the effect of omega-3 FA on oleic acid in peritoneal dialysis (PD) patients. We hypothesized that omega-3 FA can modify erythrocyte membrane FA, including oleic acid, in PD patients. In a double-blind, randomized, placebo-controlled study, 18 patients who were treated with PD for at least 6 months were randomized to treatment for 12 weeks with omega-3 FA or placebo. Erythrocyte membrane FA content was measured by gas chromatography at baseline and after 12 weeks. The erythrocyte membrane content of eicosapentaenoic acid and docosahexaenoic acid was significantly increased and saturated FA and oleic acid were significantly decreased in the omega-3 FA supplementation group after 12 weeks compared to baseline. In conclusion, erythrocyte membrane FA content, including oleic acid, was significantly modified by omega-3 FA supplementation for 12 weeks in PD patients.


Subject(s)
Erythrocyte Membrane/drug effects , Fatty Acids, Omega-3/administration & dosage , Fatty Acids/metabolism , Oleic Acid/metabolism , Peritoneal Dialysis , Adult , Dietary Supplements , Docosahexaenoic Acids/metabolism , Double-Blind Method , Eicosapentaenoic Acid/metabolism , Erythrocyte Membrane/metabolism , Female , Humans , Male , Middle Aged , Patient Dropouts , Time Factors , Treatment Outcome
6.
Clin Nephrol ; 75(3): 195-203, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21329629

ABSTRACT

AIMS: Besides regulating energy metabolism, leptin promotes and adiponectin suppresses inflammation which is a common feature of end-stage renal disease (ESRD). Omega-3 fatty acids (n-3FA) exert anti-inflammatory actions by inhibiting pro-inflammatory signal transduction pathways whereas arachidonic acid (an n-6FA) facilitates inflammation by mediating inflammatory signals and serving as precursor of pro-inflammatory eicosanoids. Given the functional overlap between adipokines and n-3FA and n-6FA, we sought to explore their interrelationship in patients with ESRD. METHODS: 44 ESRD patients maintained on hemodialysis (HD), 29 patients receiving peritoneal dialysis (PD), and 10 healthy subjects were enrolled. Body mass index (BMI), plasma leptin, adiponectin, lipids and CRP and erythrocyte fatty acids were measured. RESULTS: Compared to controls adiponectin was elevated and leptin level was reduced in the ESRD group. Adiponectin levels were comparable among PD and HD patients, but leptin and BMI were higher in PD than in HD patients. Despite comparable BMIs, female patients had higher leptin than male patients. Leptin levels were positively associations with BMI, total and LDL cholesterol whereas adiponectin was inversely related with BMI, triglycerides and CRP and directly associated with HDL cholesterol in ESRD patients. Plasma adiponectin was directly associated with erythrocyte n-3 FA (r = 0.581, p = 0.023) and inversely associated with n-6FA (r = -0.640, p = 0.010) in the HD patients. CONCLUSION: A direct association was found between plasma levels of adiponectin and HDL and erythrocyte n-3FA in ESRD patients. Prospective trials are needed to explore the effect of n-3FA supplementation on plasma adipokines and markers of oxidative stress and inflammation in this population.


Subject(s)
Erythrocytes/chemistry , Fatty Acids, Omega-3/blood , Fatty Acids, Omega-6/blood , Kidney Failure, Chronic/therapy , Leptin/blood , Peritoneal Dialysis , Renal Dialysis , Adiponectin/blood , Adult , Aged , Biomarkers/blood , Body Mass Index , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Cross-Sectional Studies , Female , Humans , Kidney Failure, Chronic/blood , Male , Middle Aged , Republic of Korea , Triglycerides/blood
7.
Transplant Proc ; 42(9): 3497-502, 2010 Nov.
Article in English | MEDLINE | ID: mdl-21094803

ABSTRACT

End-stage renal disease (ESRD) caused by diabetic nephropathy is increasing throughout the world. The survival of diabetic patients treated by transplantation has improved nowadays. Although recent studies have demonstrated preemptive kidney transplantation to be associated with better graft survival in CKD patients, the effect of pre-transplantation dialysis on graft outcomes among diabetic ESRD patients is unclear. This analysis summarized our experience with preemptive kidney transplantation in diabetic ESRD patients by retrospectively comparing 70 such patients transplanted between 1995 and 2009. These 70 patients were divided into two groups: 30 patients underwent preemptive and the other 40 transplantation after maintenance hemodialysis or peritoneal dialysis. We compared graft survivals, acute rejection episodes, postoperative complications, and delayed graft function rates. The 10-year patient survival of 100% in the preemptive group was similar to that of the nonpreemptive group (85%, P = .11). But the 10 year graft survival was higher among the preemptive than the nonpreemptive group (100% vs 75%, P = .02). Pre-transplantation modality did not affect graft survival. Therefore, preemptive kidney transplantation should be applied to eligible patients with diabetic ESRD.


Subject(s)
Diabetic Nephropathies/surgery , Kidney Failure, Chronic/surgery , Kidney Transplantation , Adult , Aged , Delayed Graft Function/etiology , Diabetic Nephropathies/complications , Diabetic Nephropathies/mortality , Disease Progression , Female , Graft Rejection/etiology , Graft Survival , Humans , Immunosuppressive Agents/therapeutic use , Kaplan-Meier Estimate , Kidney Failure, Chronic/etiology , Kidney Failure, Chronic/mortality , Kidney Transplantation/adverse effects , Kidney Transplantation/mortality , Korea , Male , Middle Aged , Patient Selection , Peritoneal Dialysis , Proportional Hazards Models , Renal Dialysis , Retrospective Studies , Risk Assessment , Risk Factors , Survival Rate , Time Factors , Treatment Outcome
8.
Water Sci Technol ; 62(5): 1003-12, 2010.
Article in English | MEDLINE | ID: mdl-20818039

ABSTRACT

The seasonal performance of four differently configured constructed wetland systems was compared for the treatment efficiency of nonpoint source pollution. Dead plants in the constructed wetlands increased the nitrogen removal rate during winter by providing organic carbon, which is essential for the denitrification process. However, when the wetlands released phosphorus from the dead plants, the removal rate of phosphorus decreased. After seven growing seasons, plant coverage was nearly 100%, and the dissolved oxygen (DO) concentration was lowered to 1.3-5.4 mg/L. Open-water sections were then constructed inside the wetlands, which resulted in enhanced DO concentrations as well as improved treatment efficiency of nutrients and biochemical oxygen demand (BOD). Overall, performance of the constructed wetland was improved BOD, total nitrogen, and total phosphorus with the establishment of open water sections in the constructed wetland system.


Subject(s)
Water Pollutants/isolation & purification , Water Pollution/prevention & control , Water Purification/methods , Water/standards , Wetlands , Waste Disposal, Fluid , Water Microbiology , Water Supply
9.
Anat Histol Embryol ; 32(2): 80-8, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12797528

ABSTRACT

This study was undertaken to investigate the immunohistochemical characterization of different subpopulations of macrophages and dendritic cells (DCs) of the spleen, thymus, tongue and heart in cyclophosphamide (CY)-induced immunosuppressed rat. After CY treatment, remarkably, ED1+, ED2+ and ED3+ macrophage subpopulations, in general exhibited signs of cellular activation such as an increase in number and size of cell, and an upregulation of the ED1, ED2 and ED3 reactive surface molecule expression in all the organs studied, except for some macrophage subpopulations including ED1+ macrophages in the non-lymphoid tissues. Subpopulations of DCs showed a differential sensitivity to CY. Lymphoid DCs were more sensitive to CY than non-lymphoid interstitial DCs. CY induced a conspicuous upregulation of intercellular adhesion molecule-1 (ICAM-1) expression in the vascular endothelial cells, splenic marginal zone and thymic cortex. In this study, we demonstrated the in vivo effects of CY treatment on subpopulations of macrophages and DCs as well as on ICAM-1 expression in the rat spleen, thymus, tongue and heart. Moreover, our results shed more light on the activation effects of CY on certain subpopulations of macrophages, on the differential sensitivity of DCs to CY between the immature and mature ones, on the functional role of different subpopulations of macrophages, and on the significance of upregulated ICAM-1 expression in the splenic marginal zone and thymic cortex after CY treatment.


Subject(s)
Cyclophosphamide/pharmacology , Dendritic Cells/drug effects , Immunosuppressive Agents/pharmacology , Macrophages/drug effects , Animals , Dendritic Cells/classification , Dendritic Cells/immunology , Immunohistochemistry/veterinary , Intercellular Adhesion Molecule-1/biosynthesis , Macrophages/classification , Macrophages/immunology , Male , Myocardium/cytology , Rats , Rats, Sprague-Dawley , Spleen/cytology , Spleen/drug effects , Thymus Gland/cytology , Thymus Gland/drug effects , Tongue/cytology , Tongue/drug effects
10.
Yonsei Med J ; 39(6): 604-10, 1998 Dec.
Article in English | MEDLINE | ID: mdl-10097689

ABSTRACT

Antimicrobial agents played a miraculous role in the treatment of bacterial infections until resistant bacteria became widespread. Besides antimicrobial-resistant bacteria, many factors can influence the cure of infection. Nocardia infection may be a good example which is difficult to cure with antimicrobial agents alone. A 66-year-old man developed soft tissue infection of the right buttock and thigh. He was given prednisolone and azathioprine for pachymeningitis 3 months prior to admission. Despite surgical and antimicrobial treatment (sulfamethoxazole-trimethoprim), the infection spread to the femur and osteomyelitis developed. The case showed that treatment of bacterial infection is not always as successful as was once thought because recent isolates of bacteria are more often resistant to various antimicrobial agents, intracellular parasites are difficult to eliminate even with the active drug in vitro, and infections in some sites such as bone are refractory to treatment especially when the patient is in a compromised state. In conclusion, for the treatment of infections, clinicians need to rely on laboratory tests more than before and have to consider the influence of various host factors.


Subject(s)
Dura Mater/microbiology , Meningitis/microbiology , Nocardia Infections/drug therapy , Osteomyelitis/microbiology , Aged , Drug Resistance, Microbial/physiology , Fatal Outcome , Femur/diagnostic imaging , Humans , Male , Nocardia Infections/physiopathology , Osteomyelitis/diagnostic imaging , Radiography , Radionuclide Imaging
SELECTION OF CITATIONS
SEARCH DETAIL
...